abstract |
The present invention relates to compounds of formula (I) and salts thereof, wherein A hasAny value defined in the specification. The compounds are useful as inhibitors of CBP and/or EP 300. The invention also includes pharmaceutical compositions comprising compounds of formula (I) or pharmaceutically acceptable salts thereof, and methods comprising using these compounds and salts thereof for treating various CBP and/or EP300 mediated disorders. |